Evidence map›Paper›PMID 38993211›Full record

ArticleBladder cancer (Amsterdam, Netherlands)2021

Evaluating Patient-Defined Priorities for Female Patients with Bladder Cancer.

Amanda X Vo, Mary Kate Keeter, Emily S Tuchman, Joshua J Meeks, Alicia K Morgans

Abstract read
In one paragraph

Article in Bladder cancer (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amanda X VoDepartment of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Mary Kate KeeterDepartment of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Emily S TuchmanDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Joshua J MeeksDepartment of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Alicia K MorgansDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough bladder cancer is much more common in men than in women, female patients with bladder cancer present with more locally advanced tumors and have worse disease-specific outcomes than male patients, even after controlling for biological differences. There is a paucity of research regarding the optimal approach to caring for female patients with bladder cancer in ways that maximize patient satisfaction, preferences, and values.

objectiveWe sought to explore patient-defined priorities and areas in need of improvement for female patients with bladder cancer from the patient perspective.

methodsWe conducted focus group sessions and semi-structured interviews of women treated for bladder cancer to identify patient priorities and concerns until reaching topic saturation. Transcripts were analyzed thematically.

resultsEight patients with muscle-invasive bladder cancer and six patients with non-muscle-invasive bladder cancer participated in two focus groups and seven interviews total. Three themes emerged as significantly affecting the care experience: physical impacts, mental health and emotional wellbeing, and the patient-provider interaction. Each theme included patient-defined specific recommendations on approaches to optimizing the care experience for women with bladder cancer.

conclusionsAlthough most participants were satisfied with the quality of care they received, they identified several opportunities for improvement. These concerns centered around enhancing support for patients' physical and mental needs and strengthening the patient-provider interaction. Efforts to address these needs and reduce gender disparate outcomes via quality improvement initiatives are ongoing.

Indexed as

patient advocacyqualitative researchquality improvementUrinary bladder neoplasms

Identifiers

PMID38993211
PMCPMC11181836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.